End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.56 SEK | -6.67% | +1.45% | +34.94% |
Apr. 16 | AcuCort AB Provides Update on Phase IV Study ZEQ001 | CI |
Mar. 07 | AcuCort AB Announces Update on FDA Application Ahead of Launch in the USA | CI |
Sales 2021 | 3.46 37.88 | Sales 2022 | 5.02 54.95 | Capitalization | 60.22M 659M |
---|---|---|---|---|---|
Net income 2021 | -11M -120M | Net income 2022 | -14M -153M | EV / Sales 2021 | 15,845,247 x |
Net cash position 2021 | 35.85M 392M | Net cash position 2022 | 17.18M 188M | EV / Sales 2022 | 8,567,999 x |
P/E ratio 2021 |
-5
x | P/E ratio 2022 |
-4.1
x | Employees | 3 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 82.14% |
1 day | -6.67% | ||
1 week | +1.45% | ||
Current month | -6.67% | ||
1 month | +11.11% | ||
3 months | +63.74% | ||
6 months | +37.25% | ||
Current year | +34.94% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 53 | 20-08-08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 17-02-07 | |
Göran Tornling
BRD | Director/Board Member | 77 | 20-12-31 |
Director/Board Member | 68 | 20-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.56 | -6.67% | 1 644 357 |
24-04-25 | 0.6 | +5.26% | 1,561,091 |
24-04-24 | 0.57 | +3.64% | 1,149,640 |
24-04-23 | 0.55 | +1.85% | 1,184,193 |
24-04-22 | 0.54 | 0.00% | 748,169 |
End-of-day quote NORDIC GROWTH MARKET, April 25, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+34.94% | 5.96M | |
-31.97% | 10.1B | |
+8.14% | 6.12B | |
-11.41% | 5.97B | |
-30.42% | 5.65B | |
-0.88% | 4.71B | |
+51.58% | 4.26B | |
-12.31% | 3.58B | |
-14.86% | 3.26B | |
-6.93% | 3.07B |
- Stock Market
- Equities
- ACUC Stock